MatthewRoeMD

PubMed

• 1 citations
  Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
  Amber Sleem, Mark B Effron, Amanda Stebbins, Lisa M Wruck, Guillaume Marquis-Gravel, Daniel Muñoz, Richard N Re, Kamal Gupta, Carl J Pepine, Sandeep K Jain, Saket Giro...> ;JAMA Cardiology. 2023 Nov 1
• 2 citations
  Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.
  Muhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M Talha, Harriette G C Van Spall, Stephen J Greene, Muthiah Vaduganathan, Sadiya S Khan, Nicholas L Mills, Ziad A...> ;European Heart Journal. 2023 Jun 1
• 2 citations
  Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical T...
  Rubina Attar, Angie Wu, Daniel Wojdyla, Svend Eggert Jensen, Pontus Andell, Kenneth W Mahaffey, Matthew T Roe, Stefan K James, Lars Wallentin, Sreekanth Vemulapalli, J...> ;The American Journal of Cardiology. 2022 Sep 1
• 4 citations
  Preexisting frailty and outcomes in older patients with acute myocardial infarction.
  Jacob A Udell, Di Lu, Akshay Bagai, John A Dodson, Nihar R Desai, Gregg C Fonarow, Abhinav Goyal, Kirk N Garratt, Joseph Lucas, William S Weintraub, Daniel E Forman, M...> ;American Heart Journal. 2022 Jul 1
• 11 citations
  The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review.
  David J Malenka, Deepak L Bhatt, Steven M Bradley, David M Shahian, Jasmine Draoui, Claire A Segawa, Christina Koutras, Jinnette D Abbott, James C Blankenship, Robert ...> ;Journal of the American College of Cardiology. 2022 May 3
• 4 citations
  Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized ...
  Guillaume Marquis-Gravel, Bradley G Hammill, Hillary Mulder, Matthew T Roe, Holly R Robertson, Lisa M Wruck, Amber Sharlow, Debra F Harris, F Will Pohlman, Adrian F He...> ;Circulation. Cardiovascular Quality and Outcomes. 2021 Dec 1
• 1 citations
  Correction to: The role of machine learning in clinical research: transforming the future of evidence generation.
  E. Hope Weissler, Tristan Naumann, Tomas Andersson, Rajesh Ranganath, Olivier Elemento, Yuan Luo, Daniel F. Freitag, James Benoit, Michael C. Hughes, Faisal Khan, Paul...> ;Trials. 2021 Sep 6
• 6 citations
  Impact of the COVID-19 Pandemic on Urological Care Delivery in the United States.
  Daniel J. Lee, Jeremy B. Shelton, Paul Brendel, Rahul Doraiswami, Danil V. Makarov, William Meeks, Raymond Fang, Matthew T. Roe, Matthew R. Cooperberg> ;The Journal of Urology. 2021 Sep 2
• 43 citations
  Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
  Renato D. Lopes, Celestia S. Higano, Susan F. Slovin, Adam J. Nelson, Robert Bigelow, P. Sørensen, Chiara Melloni, Shaun G. Goodman, Christopher P. Evans, Jan Nilsson,...> ;Circulation. 2021 Oct 19
• 58 citations
  The role of machine learning in clinical research: transforming the future of evidence generation
  E. Hope Weissler, Tristan Naumann, Tomas Andersson, Rajesh Ranganath, Olivier Elemento, Yuan Luo, Daniel F. Freitag, James Benoit, Michael C. Hughes, Faisal Khan, Paul...> ;Trials. 2021 Aug 16
• 3 citations
  Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials
  Akash Goyal, Tony Schibler, Brooke Alhanti, Karen L. Hannan, Christopher B. Granger, Michael A. Blazing, Renato D. Lopes, John H. Alexander, Eric D. Peterson, Sunil V....> ;JAMA Network Open. 2021 Jul 1
• Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments.
  Matthew T. Roe, Bray Patrick-Lake, Andrew C von Eschenbach> ;Drugs. 2021 Jun 16
• 9 citations
  Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
  Theresa Coles, Adrian F. Hernandez, Bryce B. Reeve, Karon F. Cook, Michael C. Edwards, Marc Boutin, Elizabeth Nicole Bush, Arnold Degboe, Lothar Roessig, Amy E. Rudolp...> ;Health and Quality of Life Outcomes. 2021 Jun 13
• 108 citations
  Comparative effectiveness of aspirin dosing in cardiovascular disease.
  W. Schuyler Jones, Hillary Mulder, Lisa M. Wruck, Michael J. Pencina, Sunil Kripalani, Daniel Muñoz, David L. Crenshaw, Mark B. Effron, Richard N. Re, Kamal Gupta, R. ...> ;The New England Journal of Medicine. 2021 May 15
• 15 citations
  Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial.
  Rafael Diaz, Qian H Li, Deepak L Bhatt, Vera A Bittner, Marie T Baccara-Dinet, Shaun G Goodman, J Wouter Jukema, Takeshi Kimura, Alexander Parkhomenko, Robert Pordy, Ž...> ;European Journal of Preventive Cardiology. 2021 Mar 23
• 42 citations
  Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease.
  Michel Zeitouni, Robert M. Clare, Karen Chiswell, Jawan W. Abdulrahim, Nishant P. Shah, Neha P. Pagidipati, Svati H. Shah, Matthew T. Roe, Manesh R. Patel, W. Schuyler...> ;Journal of the American Heart Association. 2020 Dec 15
• 3 citations
  Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.
  Daniel L. Edmonston, Matthew T. Roe, Geoffrey A. Block, Paul T. Conway, Laura M. Dember, Peter M DiBattiste, Tom Greene, Ali Hariri, Lesley A. Inker, Tamara Isakova, M...> ;American Journal of Kidney Diseases. 2020 Dec 1
• 6 citations
  Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
  Guillaume Marquis-Gravel, Megan L. Neely, Marco Valgimigli, Francesco Costa, David van Klaveren, Rituparna Altner, Deepak L. Bhatt, Paul W. Armstrong, Keith A.A. Fox, ...> ;Circulation. Cardiovascular Quality and Outcomes. 2020 Aug 31
• 4 citations
  Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial.
  Rafael Diaz, Qian H. Li, Deepak L. Bhatt, Vera Bittner, Marie T. Baccara-Dinet, Shaun G. Goodman, J. Wouter Jukema, Takeshi Kimura, Alexander Parkhomenko, Robert Pordy...> ;European Journal of Preventive Cardiology. 2020 Jul 27
• Leveraging electronic health record data for pragmatic randomized trials.
  Matthew T. Roe> ;Clinical Trials. 2020 Jul 15
• 8 citations
  Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout
  Anthony P. Carnicelli, Robert M. Clare, Karen Chiswell, Barbara L. Lytle, Magnus K. Bjursell, Shira Perl, Karolina Sundell Andersson, Katarina Hedman, Neha J. Pagidipa...> ;The American Journal of Cardiology. 2020 Jul 15
• 41 citations
  Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.
  Guillaume Marquis-Gravel, Frederik Dalgaard, Aaron D. Jones, Yuliya Lokhnygina, Stefan James, Robert A. Harrington, Lars Wallentin, Philippe Gabriel Steg, Renato D. Lo...> ;Journal of the American College of Cardiology. 2020 Jul 14
• 47 citations
  Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients From 12 Randomized Trials
  Eliano Pio Navarese, Safi U. Khan, Michalina Kołodziejczak, Jacek Kubica, Sergio Buccheri, Christopher P. Cannon, Paul A. Gurbel, Stefano De Servi, Andrzej Budaj, Anto...> ;Circulation. 2020 Jul 14
• 1 citations
  University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials-challenges and oppo...
  Denise Esserman, Benjamin A. Goldstein, Mark Levenson, Richard Platt, Matthew T. Roe, Steve Zeliadt> ;Clinical Trials. 2020 Jul 2
• 43 citations
  Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
  Peter Sinnaeve, Gregory G. Schwartz, Daniel Wojdyla, Marco Alings, Deepak L. Bhatt, Vera Bittner, Chern-En Chiang, Roger M Correa Flores, Rafael Diaz, Maria Dorobantu,...> ;European Heart Journal. 2020 Jun 21
• Join now to see all

Journal Articles

• Coronary the Association of Frailty with in-Hospital Bleeding Among Older Adults with Acute Myocardial Infarction: Insights from the ACTION Registry  
  Kirk N Garratt, Judith S Hochman, Anita Y Chen, Gregg C Fonarow, Martha Gulati, Karen P Alexander, Matthew T Roe, John A Dodson, Martha J Radford, Sarwat I Chaudhry, ScienceDirect
• Alirocumab and Cardiovascular Outcomes After Acute Coronary Syndrome  
  Vera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine